Presentation Information

3:00 PM - 3:30 PM JST(6:00 AM - 6:30 AM UTC)

[S2-07(Invited)]Development of At-211 YF2, a PSMA-targeted agent: from bench to bedside, and academia to industry

*Yutian Feng Feng¹ (1. Duke University Medical Center (United States of America))

Astatine-211,PSMA,Targeted Alpha Therapy,Isotope Supply